These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2548090

  • 1. Effect of cisplatin, lipopolysaccharide, muramyl dipeptide and recombinant interferon-gamma on murine macrophages in vitro. II. Production of H2O2, O2- and interleukin-1.
    Sodhi A, Geetha B.
    Nat Immun Cell Growth Regul; 1989; 8(2):108-16. PubMed ID: 2548090
    [Abstract] [Full Text] [Related]

  • 2. Effect of cisplatin, lipopolysaccharide, muramyl dipeptide and recombinant interferon-gamma on murine macrophages in vitro. I. Macrophage-mediated tumor cell lysis.
    Geetha B, Sodhi A.
    Nat Immun Cell Growth Regul; 1989; 8(2):100-7. PubMed ID: 2503714
    [Abstract] [Full Text] [Related]

  • 3. Effect of cisplatin, rIFN-Y, LPS and MDP on release of H2O2, O2- and lysozyme from human monocytes in vitro.
    Pai K, Sodhi A.
    Indian J Exp Biol; 1991 Oct; 29(10):910-5. PubMed ID: 1667647
    [Abstract] [Full Text] [Related]

  • 4. Effect of cisplatin and other biological response modifiers on the activity of lysozyme, plasminogen activator and 5' nucleotidase by murine macrophages in vitro.
    Geetha B, Sodhi A.
    Biochem Int; 1990 Dec; 22(6):1103-14. PubMed ID: 2128598
    [Abstract] [Full Text] [Related]

  • 5. Induction of membrane-associated interleukin 1 alpha (IL-1 alpha) by synergistic activation of human blood monocytes with interferon gamma and muramyl dipeptide analog.
    Okubo A, Sone S, Tanaka M, Fukuta K, Inamura N, Nakanishi M, Maeda K, Yanagawa H, Nishioka Y, Yamashita C.
    Tokushima J Exp Med; 1989 Dec; 36(3-4):97-105. PubMed ID: 2484023
    [Abstract] [Full Text] [Related]

  • 6. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
    Le Contel C, Temime N, Charron DJ, Parant MA.
    J Immunol; 1993 May 15; 150(10):4541-9. PubMed ID: 8482846
    [Abstract] [Full Text] [Related]

  • 7. Studies on the release of interleukin-1 (IL-1), tumor necrosis factor (TNF) and lysozyme from human non-adherent mononuclear cells (nMNC) in vitro after treatment with cisplatin and other biological response modifiers.
    Sodhi A, Pai K.
    Neoplasma; 1992 May 15; 39(4):211-7. PubMed ID: 1436230
    [Abstract] [Full Text] [Related]

  • 8. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.
    Drapier JC, Wietzerbin J, Hibbs JB.
    Eur J Immunol; 1988 Oct 15; 18(10):1587-92. PubMed ID: 3142779
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of Fc receptor expression in guinea pig peritoneal exudate macrophages by muramyl dipeptide or lipopolysaccharide.
    Yagawa K, Kaku M, Ichinose Y, Nagao S, Tanaka A, Aida Y, Tomoda A.
    J Immunol; 1985 Jun 15; 134(6):3705-11. PubMed ID: 2985692
    [Abstract] [Full Text] [Related]

  • 10. Strain dependence of muramyl dipeptide-induced LAF(IL 1) release by murine-adherent peritoneal cells.
    Abehsira-Amar O, Damais C, Parant M, Chedid L.
    J Immunol; 1985 Jan 15; 134(1):365-8. PubMed ID: 3871106
    [Abstract] [Full Text] [Related]

  • 11. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
    Saiki I, Fidler IJ.
    J Immunol; 1985 Jul 15; 135(1):684-8. PubMed ID: 3923117
    [Abstract] [Full Text] [Related]

  • 12. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
    Utsugi T, Sone S.
    J Immunol; 1986 Feb 01; 136(3):1117-22. PubMed ID: 3079797
    [Abstract] [Full Text] [Related]

  • 13. Augmentation by priming with interferon-gamma of the binding of a muramyl dipeptide derivative to macrophages resulting in synergistic macrophage activation.
    Nagao S, Sato K, Osada Y.
    Jpn J Cancer Res; 1987 Jan 01; 78(1):80-6. PubMed ID: 3102442
    [Abstract] [Full Text] [Related]

  • 14. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.
    Ding AH, Nathan CF, Stuehr DJ.
    J Immunol; 1988 Oct 01; 141(7):2407-12. PubMed ID: 3139757
    [Abstract] [Full Text] [Related]

  • 15. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
    Hogan MM, Vogel SN.
    J Immunol; 1988 Dec 15; 141(12):4196-202. PubMed ID: 3143760
    [Abstract] [Full Text] [Related]

  • 16. [The immunomodulating activity of new muramyl dipeptide derivatives in vitro].
    Medvedev AE, Fuks BB, Bovin NV, Zemliakov AE.
    Biull Eksp Biol Med; 1992 Dec 15; 114(12):626-8. PubMed ID: 1292694
    [Abstract] [Full Text] [Related]

  • 17. Scavenger receptor A mediates H2O2 production and suppression of IL-12 release in murine macrophages.
    Józefowski S, Kobzik L.
    J Leukoc Biol; 2004 Nov 15; 76(5):1066-74. PubMed ID: 15316030
    [Abstract] [Full Text] [Related]

  • 18. Synergistic generation of tumoricidal macrophages by muroctasin and interferon-gamma.
    Nagao S, Sato K, Osada Y.
    Arzneimittelforschung; 1988 Jul 15; 38(7A):999-1002. PubMed ID: 3142490
    [Abstract] [Full Text] [Related]

  • 19. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12.
    Shnyra A, Brewington R, Alipio A, Amura C, Morrison DC.
    J Immunol; 1998 Apr 15; 160(8):3729-36. PubMed ID: 9558074
    [Abstract] [Full Text] [Related]

  • 20. Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma.
    Edwards CK, Hedegaard HB, Zlotnik A, Gangadharam PR, Johnston RB, Pabst MJ.
    J Immunol; 1986 Mar 01; 136(5):1820-7. PubMed ID: 3005400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.